# Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults

> **NCT02272049** · PHASE1,PHASE2 · RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 300 (estimated)

## Conditions studied

- Respiratory Disorders

## Interventions

- **DRUG:** Hyperpolarized 129 Xenon

## Key facts

- **NCT ID:** NCT02272049
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2014-12
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-08-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02272049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02272049, "Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02272049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
